论文部分内容阅读
Purpose To evaluate the efficacy and safety of clofarabine in pediatric patients with refractory andrelapsed (R/R) acute lymphoblastic leukemia (ALL).Patients and Methods A phase II,non-randomized multi-center study was conducted withsingle-agent clofarabine in pediatric patients with refractory or relapsed ALL.